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Bioprocess forces such as shear stress experienced during routine cell culture are considered to be harmful to cells. However, the
impact of physical forces on cell behavior is an area of growing interest within the tissue engineering community, and it is widely
acknowledged that mechanical stimulation including shear stress can enhance osteogenic diﬀerentiation. This paper considers the
eﬀects of bioprocess shear stress on cell responses such as survival and proliferation in several contexts, including suspension-
adapted cells used for recombinant protein and monoclonal antibody manufacture, adherent cells for therapy in suspension, and
adherent cells attached to their growth substrates. The enhanced osteogenic diﬀerentiation that fluid flow shear stress is widely
found to induce is discussed, along with the tissue engineering of mineralized tissue using perfusion bioreactors. Recent evidence
that bioprocess forces produced during capillary transfer or pipetting of cell suspensions can enhance osteogenic responses is also
discussed.
1. Introduction
One of the most recent and exciting advances in modern
medicine is the emerging field of regenerative medicine,
where live cell-based therapies are used to restore function
to ailing tissues and organs. The key challenge still faced for
successful commercialisation of cell therapies is their produc-
tion on a large scale [1, 2]. Consequently, the bioprocessing
steps involved in the manufacture of cell therapies have to
be scalable and capable of producing cellular products of a
reproducibly high quality [2]. It is important that the cells
maintain their integrity throughout the whole bioprocess
and that the resulting cell product has the appropriate
functional identity that is required for therapy. In order to
achieve this, it is essential to have a detailed understanding of
how the bioprocessing environment impacts on the cells at
both the laboratory and industrial manufacture scales.
Cell behavior is influenced and aﬀected by the microen-
vironment in which they reside. In vivo, cells are exposed
to a combination of both biochemical and physical cues
that regulate their function. Biochemical stimuli such as
growth factors and chemokines stimulate a wide range of
responses by binding to their appropriate receptors and
initiating intracellular signaling pathways. Physical cues can
be provided by other cells or matrix components and be
passive in nature or the result of applied force.
Bioprocessing of cells for therapy involves ex vivo expan-
sion and diﬀerentiation in an artificial microenvironment
[1]. Therefore, careful consideration has to be given to the
impact that this artificial environment will have on cells
that will be transplanted into a patient. It is important
that nutrients and growth factors are delivered in suitably
formulated growth medium, providing the cells with the
appropriate nutritional support. It is also important to
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monitor and control the physicochemical environment, as
subtle changes in temperature, O2, CO2, and pH will all
potentially alter cell behaviour. A further consideration that
is often overlooked in basic science research is the impact of
bioprocess forces on those cells. Bioprocess forces encoun-
tered during cell culture include hydrodynamic shear caused
by shaking of the flasks to aid their detachment following
trypsinisation, forces produced during centrifugation prior
to resuspending and shear stresses resulting from transfer
through capillaries or by pipetting to resuspend cell pellets
[3]. To date, few studies have been conducted to assess the
impact of bioprocess forces on human stem-cell populations,
but by understanding their impact on suspension-adapted
mammalian cells, combined with evidence of the impact of
shear stress on stem cell populations, we can begin to develop
an understanding of the impact that bioprocess forces will
have on stem-cell survival, proliferation, and diﬀerentiation
capacity in vitro. Furthermore, we review evidence that shear
stress can enhance cellular responses in the context of bone
regeneration strategies.
2. The Impact of Bioprocess Forces on
Recovery, Viability, and Proliferation of
Mammalian Cells
2.1. Suspension-Adapted Cell Lines. Suspension adapted
mammalian cells are commonly used in the biopharmaceu-
tical industry for the production of monoclonal antibodies
and recombinant proteins. Stirred tank and air-lift biore-
actors are extensively used in the culturing of these cells
(Figure 1(a)) and whilst increasing agitation improves mix-
ing and nutrient transport, which is necessary to achieve high
purity and yield of therapeutic product, they can also cause
harm to the cells. Stirring and sparging of the suspension
culture results in the formation of spatial diﬀerences in the
pattern of liquid flow, leading to cell damage caused by
hydrodynamic shear stress [4–6]. Undesired cell lysis can
aﬀect the stability of therapeutic protein products due to the
large amounts of proteases that are released from the dying
cells, making purification of the target protein diﬃcult [7, 8].
Many studies have been carried out to investigate the
sensitivity of suspension-adapted mammalian cells to shear
forces, and there is an overwhelming consensus that shear
forces are damaging to these cells [9–11]. Turbulent shear
stress is generally thought to be more damaging to cells than
laminar shear stress of the samemagnitude [12–14]. In terms
of the critical level of shear stress that cells can withstand,
there is great variation in opinion as to what magnitude of
shear stress is harmful. One notable study reported that cell
loss at high shear stress (100Nm−2) and low shear stress
(1Nm−2) is greater than that at intermediate shear stress
(10Nm−2) for several animal cell lines in stirred-bioreactors
[15]. Cell lysis at high shear is caused by the applied shear
force exceeding the cell bursting force, whereas the damage
caused at low shear stress is mainly due to the papillated
state of the cell, something that occurs when the turgor
pressure pushes the cytoplasm out through transient pores
formed in the cell [15]. At high levels of hydrodynamic shear
stress (induced by high intensity agitation of 1500 rpm in a
turbine impeller baﬄed fermenter), the viability of murine
hybridoma cells is aﬀected [14].
Studies conducted on suspended human cells such as
primary T-cells suggested that no immediate eﬀects were
observed on the metabolism or the extent of apoptosis
as a result of hydrodynamic forces arising from agitation
or sparging, up to agitation rates of 180 rpm [16]. Even
so, the overall expansion potential of the population was
reduced due to rapid downregulation of the interleukin-2
receptor. However, in the same study, transformed T cells
were extremely sensitive, with reduced growth rates recorded
even at agitation rates as low as 30 rpm [16].
In 1992, Born and colleagues proposed a cell-damage
model [9]. The model proposed that cell loss is independent
of duration of exposure to shear stress as a cell exposed to
laminar shear stress is either disrupted or unaﬀected [9].
However, this model may apply specifically to suspension-
adapted cells, because for adherent cells in suspension,
increased shear stress exposure time results in an increase in
cell damage [11, 17–19].
The large variation in susceptibility of cells in suspension
to shear damage is dependent not just on the specific cell type
but also on inherent variation within a single population of
cells. For instance, the susceptibility of cells to hydrodynamic
damage can vary as they move through the cell cycle, with
larger cells in S and G2 phase being more prone to damage
than G1 cells, presumably due to their size [14].
Many studies have been conducted on haematopoietic
cells, as they have an important role in the development of
newmedicines and therapeutics. Furthermore, they are often
in suspension in vivo and, hence, experience hydrodynamic
shear stress, something that cells are likely to encounter
during cell bioprocessing, for example during capillary
transfer [1, 4, 9]. The use of erythrocytes as a cellular
standard for comparative analysis of the damage caused by
hydrodynamic shear stress has been suggested by Zhang
et al. [20]. The main advantage of using erythrocytes is that
they do not multiply in vitro so the eﬀects of cell damage
can be seen clearly, without apoptosis events in some cells
being obscured by the impact of proliferation in others.
Studies of erythrocytes from diﬀerentmammals revealed that
the critical shear stress cells can experience without losing
viability increases significantly as the cell volume decreases,
further demonstrating the relationship between cell size and
susceptibility to shear stress [9]. Another type of circulating
haematopoietic cells that experience hydrodynamic shear
stress are leukocytes. The requirement for these cells to
withstand shear stress in vivo results from their adhesion
to vascular endothelium when migrating to sites of tissue
damage or infection. The continual flow of blood past
these cells exposes them to shear stress and detachment of
leukocytes adhering to vascular endothelium occurs when
shear stresses are in the range of 26.5–106.0Nm−2 [21].
Additionally, shear stress of 60Nm−2 applied to leukocytes
in vitro for duration of 10 minutes will lyse around 25% of
the population [12], and this demonstrates that shear stress
levels that can detach leukocytes from vascular endothelium
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also have debilitating eﬀects on those cells when applied in
vitro.
2.2. Adherent Cells in Suspension. Experience gained from
suspension-adapted mammalian cells used for production
of vaccines, recombinant proteins and antibodies provides
valuable insights that can be applied to the scalable manu-
facturing of stem cell-based therapies, but because the cells
themselves are the therapeutic product, bioprocess forces
might, either favourably or unfavourably, alter the phenotype
of those cells [1, 3, 17–19, 22]. This is one of the factors that
make cell-based therapeutics more challenging to produce
at scale than protein-based therapeutics [23]. However,
advancement of the regenerative medicine field relies on the
ability to expand and diﬀerentiate stem cells into suitable
candidates for therapy ex vivo, and consequently, bioprocess
forces are unavoidable (Figures 1 and 2(c)).
Bioprocess forces experienced during the isolation of
primary cells from tissues for ex vivo expansion have to
be considered carefully, as they may introduce a source
of poorly characterized stimuli to the cells that can alter
their phenotype even before the onset of expansion and/or
diﬀerentiation. Harvesting of bone marrow requires physical
removal from the marrow cavity, introducing low-level shear
stress (due to the large diameter of the 11G biopsy needle
∼3mm) during capillary transfer. However, when obtaining
adipose tissue as a source of adipose-derived stem cells,
procedures often involve mechanically abrasive and high
shear stress during suction of often-fibrous adipose tissue.
For other tissue types, such as retrieval of dermal fibroblasts
for the production of induced pluripotent cells, the forces
encountered during retrieval of primary tissue are minimal,
as tissue biopsy needles have a large diameter (∼6mm), and
hence, the majority of cells do not experience mechanical
force. However, when liberating these cells from the col-
lagenous matrix, shear stresses are unavoidably encountered
during mechanical digestion of ECM components.
Once isolated, routine passaging of cells subjects them
to shear stress caused by pipetting, capillary transfer, and
centrifugation [3]. The limited work conducted on adherent
cells in suspension to date suggests that cells from diﬀerent
sources have diﬀering capacities to withstand shear stress
[3, 17–19, 22] and numerous physical properties are likely
to impact such as cell size, density, membrane strength, and
flexibility and surface characteristics such as cohesion [22].
Even functionally distinct subsets of a cell population from a
single tissue can tolerate shear stress to diﬀerent degrees [18].
In order to mimic the eﬀect of manual pipetting under
constant, reproducible flow rates, Veraitch et al. [3] used
a capillary fluid flow device to determine the impact of
shear stress on two murine embryonic stem cell lines.
Repeated passes through the capillary at a flowrate of
0.80mLs−1 did not cause a significant drop in viability, but
a small decline in total cell number recovered was noted
with increasing number of capillary passes [3]. This loss
was attributed to surface adhesion to the syringe barrel and
overall demonstrates the robustness of these cells.
However, the robustness of murine embryonic stem
cells is not universally noted in other sources of adherent
mammalian cells. Studies indicate that shear stress can be
debilitating to adult primary cells including bone marrow-
derived mesenchymal stem cells (MSCs) [24], muscle-
derived multipotent precursor cells [18, 19], and vascular
smooth muscle cells [17, 22]. Cultured rat aortic smooth
muscle cells repeatedly exposed to (lamina) wall shear stress
between 2–120Nm−2 by passing back and forth through a
narrow-gauge capillary underwent a decline in cell number
with increasing number of capillary passes, indicating that
cell damage took place during each capillary pass [17]. A
large proportion of the cell population survived repeated
exposure to shear stress, and this was postulated to be
either due to the cells travelling along the centre of the
capillary and hence not experiencing damaging levels of
shear stress; or heterogeneity in membrane strength (burst
tension) throughout the cell population. The optimum wall
shear stress for cell survival was found to be 10–50Nm−2,
which is similar to that reported by others for low adherence
leukaemic cells [15]. Subsequent studies also demonstrated
cell loss at low shear stress (0.5, 1.0Nm−2) during capillary
transfer but this was not a result of cell disruption, rather
cell attachment to the capillary wall at low flow rates [22].
This phenomenon mirrors that in vivo, where circulating
leukocytes attach to vascular endothelium [25, 26].
The debilitating eﬀects of flow-induced shear stress were
also observed when murine MSCs were passed through
needles of various bore sizes [24]. A direct relationship
between the bore diameter of the needle, flow rate and
cell trauma was evident. When needle bore diameter was
decreased or flow rate was increased, cell viability, spreading,
and proliferation were all seen to decrease [24]. Increased
production of caspase-3 protein, an early indicator of
apoptosis, was also reported. Subsequent studies of murine
muscle-derived precursor cells exposed to high wall shear
stress using the same capillary fluid flow system as Zoro
et al. [17, 22] indicate that the eﬀect of shear stresses
may not be immediately observed, as viable cell recovery
immediately following exposure to high capillary wall shear
stress was not significantly aﬀected [19]. However, after 24
hours, a significant reduction in cell viability was evident,
similar to the reports of apoptosis reported for murine MSCs
[24]. Interestingly, there seems to be diﬀerential ability of
functionally distinct cell subsets isolated from a single tissue
to withstand the eﬀects of shear stress, based on our recent
observation that rapidly adherent cells isolated from murine
muscle are more susceptible to damage caused by capillary
fluid flow-induced shear stress than late adherent cells from
the same population [18].
Manual processing can introduce several sources of
bioprocess forces (e.g., when detaching trypsinised cells from
the culture dish and resuspending cell pellets) that are
highly variable between operators and the impact of diﬀerent
forces on cells being prepared for therapy can potentially
be of detriment to those cells. Automated approaches may
overcome the variability and enable the bioprocess forces
experienced by cells to be controlled to a greater degree,
but still, these forces will remain. However, bioprocess forces
do not necessarily have to be viewed as debilitating to cells
and there is an emerging body of evidence suggesting that
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Figure 1: Diﬀerent circumstances in which mammalian cells become exposed to shear stress that can impact on their behavior. (a) During
the manufacture of biopharmaceuticals such as recombinant proteins or monoclonal antibodies, shear stress encountered by suspension-
adapted cells in stirred tank bioreactors is often considered harmful. (b) Adherent cells can experience shear stress as a mechanical
stimulus that promotes osteogenic diﬀerentiation and this can be exploited in perfusion bioreactors, where active transport of oxygen and
nutrients throughout 3D scaﬀolds exposes cells to shear stress. (c) Bioprocess forces produced during manual processing of multipotent cell
populations can also enhance osteogenic diﬀerentiation potential.
∗ ∗
∗
(a) 2D planar culture (b) 3D perfusion culture (c) Manual processing forces
during cell preparation
Figure 2: The application method and magnitude of shear stress can both impact on cell survival, proliferation and osteogenic
diﬀerentiation. (a) Cells cultured in 2D and subjected to fluid flow shear stress, for example using parallel plate perfusion systems, are
exposed to shear stress in one plane at the exposed surface of the cells and relatively high shear stress drives osteogenic diﬀerentiation. (b) In
3D perfusion culture, typically used when seeding cells throughout biomaterial scaﬀolds, cell dynamics are diﬀerent: some cells are flattened
and adhered firmly to the scaﬀold surface. These cells (shown in purple) experience shear stress at their exposed surface similar to those
cultured in 2D culture. Other cells bridge between scaﬀold components and these cells (shown in green) experience shear stress as a 3D
stimulus. Consequently, lower levels of shear stress than those required in 2D culture can drive osteogenic diﬀerentiation. (c) Bioprocess
forces experienced during pipetting and capillary transfer of adherent cells in suspension provide non-uniform shear stress stimuli in the
form of wall shear stress as the cells randomly hit the capillary walls during transport (red stars). Furthermore, shear stress and extensional
forces upon entry to the capillary may provide further positive mechanical stimulus (green star). Red arrows indicate initial direction of fluid
flow.
bioprocess forces that cells experience during capillary trans-
fer can actually be beneficial in some contexts. They can, for
example, be used to enhance osteogenic diﬀerentiation and
synthetic activity in muscle-derived multipotent precursor
cells [18, 19]. It has been observed using in vitro models that
even short-term exposure of these multipotent precursor
cells to fluid flow shear stress during capillary transfer upon
passaging can enhance osteogenic diﬀerentiation beyond
that induced by defined osteogenic medium alone and
that functionally distinct subsets, isolated on the basis
of diﬀerential adhesion capacity, have diﬀerent intrinsic
osteogenic potential [18].
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2.3. Adherent Cells Attached to Surfaces. Understanding
the impact of flow-induced shear stress on adherent cell
responses provides useful information for production of cell-
based therapies and tissue-engineered constructs. Seeding
cells throughout 3D porous scaﬀolds using perfusion meth-
ods for even distribution exposes those cells to shear stress.
Even low levels of shear stress (0.25–0.60N·m−2) can inter-
fere with attachment of anchorage-dependent mammalian
cells to surfaces [27]. Exposing baby hamster kidney cells to
shear stress using a flow chamber demonstrated that critical
shear stress of 0.75–1.0Nm−2 applied for 24 h resulted in
decreased cell viability [28], and hence, careful control of
perfusion rate is necessary.
Expanding adherent cells in perfusion bioreactors or
on microcarriers in stirred bioreactors may potentially be
advantageous for producing large quantities of cells in con-
trolled environment, where the critical culture parameters
can be monitored and controlled [29]. Hematopoietic stem
cells (HSCs) were one of the first potential therapeutic
stem-cell populations to be studied in such bioreactors and
expansion is often carried out in stirred or suspension culture
[30, 31]. MSCs, on the other hand, that are often explored
for their potential use in tissue engineering for skeletal
regeneration aremostly cultured on 3D scaﬀolds in perfusion
bioreactors [29]. The main advantage of using continuous
perfusion with fresh or recycled medium is that oxygen
transport to the cells within the scaﬀold is increased [32].
A number of studies have confirmed that perfusion biore-
actor culture for 3D tissue production facilitates uniform
distribution of cells with MSC proliferation being achievable
without loss of multilineage diﬀerentiation potential [33–
37]. This is very encouraging, because being able to direct the
expansion of cells as well as their diﬀerentiation within 3D
scaﬀolds in vitro is crucial for successful tissue engineering.
Furthermore, osteogenic induction of MSCs expanded and
diﬀerentiated in 3-D scaﬀolds under perfusion flow condi-
tions is enhanced compared to static culture [38–40] and this
is, therefore, of benefit for production of mineralized tissue.
3. Fluid Flow Shear Stress Is a Bioprocess Force
that Potentiates Intracellular
Signaling and Osteogenic Responses
In vivo, bone tissue is continually exposed to mechanical
stresses. The hard mineralized matrix protects cells against
the full impact of load bearing. However, it is hypothesized
that these macroscale forces lead to pressure diﬀerences on
fluid contained within the uncalcified matrix immediately
surrounding the mature bone cells (osteocytes) throughout
the bone matrix [41, 42]. The pressure diﬀerences result in
flow of interstitial fluid through the pores and channels in
the bone [42], essentially converting the macroscale forces
to microscale shear stresses that mechanically stimulate the
osteocytes. It has been predicted that in vivo, a fluid shear
stress of between 8–30 dyn/cm2 is experienced by bone cells
as a result of interstitial fluid flow [43]. Communication net-
works that span from the marrow to the periosteum ensure
coordinated activity of osteoblasts, osteoclasts, immature
osteoprogenitors and bone marrow stromal cells to maintain
the continual bone remodeling that occurs [41]. In vitro
studies indicate that mature osteocytes are more sensitive
to mechanical forces such as fluid flow shear stress than
osteoblasts are, determined by more rapid and sustained
production of prostaglandin E2 in response to mechanical
stimulation [44, 45], and it has been hypothesized that in
vivo, the osteocytes, therefore, are themainmechanosensitive
cells, responding to fluid flow shear stresses by producing
factors that regulate bone metabolism [44].
However, osteoblasts also respond to fluid flow shear
stress in vitro and temporary exposure to fluid shear stress
of 6 dyn/cm2 was shown to stimulate sustained release
of nitric oxide, an osteoblast mitogen for up at least 12
hours following exposure [46]. Osteoblasts exposed to fluid
flow shear stress experience enhanced phosphorylation of
mitogen activated protein kinase (MAPK) intracellular signal
transduction proteins, especially those in the extracellular
signal-related kinase (ERK) pathway, which is also activated
by mitogenic growth factors such as epithelial growth factor,
insulin-like growth factor, and basic fibroblast growth factor
[41, 47]. This physical mitogenic stimulus drives prolifera-
tion of osteoblasts in an ERK-dependent fashion [48–51].
Knockdown of either ERK-1 or ERK-2 resulted in complete
abolition of shear stress-induced proliferation [49]. Fluid
flow shear stress also induces proliferation via the PI3K/AKT
signaling pathway via a focal adhesion kinase (FAK)/Shc-
dependent mechanism upon activation of integrin receptors
[52].
MAPK signaling also stimulates the expression of oste-
oblast-specific genes including early growth response-1, c-
fos proto-oncogene, cyclooxygenase-2, type I collagen and
osteopontin [53–58] downstream of integrin activation due
to fluid shear stress. αvβ3- and β1-containing integrins
are specifically reported to mediate mechanotransduction
in osteoblasts exposed to shear stress [52, 55, 59] and
their mechanotransduction activity is more readily sustained
on fibronectin than on type I collagen or laminin [55].
Integrin-mediated mechanotransduction and gene expres-
sion in response to shear stress can be further augmented
by additional signals, such as estrogen [60]. In addition
to enhanced proliferation and osteogenic gene expression
by osteoblasts in response to shear stress, their functional
diﬀerentiation towards a mineralizing phenotype is also
enhanced, as determined by increased or sustained alkaline
phosphatase production [50], secretion of osteogenic pro-
teins: osteopontin, osteocalcin, decorin, and type I collagen
[61], and increased calcified matrix deposition [61]. The
enhanced cellular responses of osteoblasts to shear stress
indicate that this form ofmechanical stimulation can provide
appropriate cues for bone induction pathways and fluid
flow shear stress is a much more potent cue for enhanc-
ing osteoblast regenerative responses than other forms of
mechanical stimulation [62, 63].
In multipotent MSCs, the impact of shear stress on
osteogenic diﬀerentiation has also been studied in some
detail. It is an appropriate stimulus for the recruitment of
MSCs from the bone marrow to sites of injury and enhances
their osteogenic diﬀerentiation [64–66]. This information is
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very useful for tissue engineering, because it suggests that
the kind of stresses created when dynamic culture methods
necessary for 3D scaﬀolds are used can be beneficial, rather
than inhibitory for osseoinduction.
Whilst the stimulatory eﬀect of shear stress on osteoblast
proliferation is well known [48–51], its impact on undif-
ferentiated MSCs remains controversial. Conflicting reports
have been made when studying shear stress in 2D culture
with descriptions of either enhanced proliferation [64, 67],
reduced proliferation and cell number decline [68, 69], or
no net diﬀerence in overall cell number [70] in response to
fluid flow shear stress compared to nonsheared controls. In
the studies where increased proliferation was reported, the
cell monolayer was exposed to oscillatory fluid flow of 1Hz
and a shear stress of 10 dyn/cm2 for 2 h, and proliferation
was assessed after 24 h [64]. In studies where lack of cell
growth was reported, shear stress was applied at constants
levels of between 0.012–2.7 dyn/cm2, an order of magnitude
lower [68–70]. It is diﬃcult to determine what variables
might impact on MSC proliferation as the form of appli-
cation, magnitude and frequency of shear stress could have
varying eﬀects, so too could variability between the MSC
populations used in diﬀerent studies. For example, Kreke
et al. [69] hypothesized that as MSCs are undiﬀerentiated,
cell loss could be due to apoptosis and/or detachment of
an immature, nonosteogenic subset of cells that is unable
to respond with appropriate mechanotransduction and
osteogenic specification. This was further supported by their
observation of elevated normalised alkaline phosphatase
activity in the remaining cell population and after 20 days
culture with exposure to fluid flow shear stress every 2nd day,
very highmRNA levels for osteopontin and bone sialoprotein
were detected, along with decreased mRNA levels of adi-
pogenic marker lipoprotein lipase, suggesting that osteogenic
selection had taken place [69]. In another study, decreased
MSC proliferation upon exposure to uniform shear stress
of 1.2 × 10−3 N/m2 (equivalent of 0.012 dyn/cm2) for 10
days was reported, but so too was significantly higher type
I collagen levels and high intensity of von Kossa staining of
mineralized matrix [68].
This notion of “osteogenic selection” of undiﬀerentiated
MSCs is not uncommon. In other studies characterizing
the influence of titanium implant microtopography on
diﬀerentiation of MSCs, a similar observation of osteogenic
cell selection was made—whereas osteoblast proliferation
was enhanced on microrough titanium compared to smooth
polished surfaces [71], MSCs underwent a significant decline
[72]. In spite of this decline, their ultimate ability to
produce calcified matrix on microrough surfaces was greatly
enhanced, suggesting that the physical environment selects
MSCs that have osteogenic induction potential and is
damaging to those that do not.
Shear stress has a pivotal role in regulating the transition
from progenitor cell proliferation to osteogenic induction to
maturation. It has been observed to directly stimulate and
enhance expression of osteogenic genes including alkaline
phosphatase, osteopontin, bone sialoprotein, and osteocalcin
[69, 70, 73], and in parallel to elevated alkaline phosphatase
levels, a decline in type I collagen gene expression has
been reported [73] indicating that shear stress can invoke
this transition away from matrix production towards cal-
cification and mineralization. Decreased type I collagen
expression was reported to be ERK-mediated, whereas
the concurrent increase in alkaline phosphatase expression
was dependent on p38 MAP kinase, activated in response
to 12 dyn/cm2 fluid flow shear stress [73]. In an earlier
study applying shear stress levels of 2.3 dyn/cm2, increased
phosphorylation of p38 and ERK was evident within just 30
minutes after stimulation [74].
Mechanical stimulation of MSCs can enhance the acti-
vation of several matrix metalloproteases (MMPs) and their
inhibitors, the tissue inhibitors of metalloproteases (TIMPs),
which may further regulate osteogenic events. Specifically,
collagenase activity associated withMMP2,MMP9,MMP13,
and TIMP2 was elevated in MSCs in response to mechanical
stimuli [75–77] and this was related to posttranslational
activation, as mRNA expression levels were not aﬀected
by the mechanical signal [77]. MMP13 in particular is
reported to be involved in osteogenic diﬀerentiation of MSCs
[77]. The precise nature of osteogenesis enhancing eﬀects
that MMPs have on MSCs remains to be determined, but
candidate mechanisms include exposure of cryptic binding
domains by cleavage of ECM components [78, 79], release
of matrix-bound bioactive molecules [78] and alterations in
matrix architecture and assembly [78], which may facilitate
cytoskeletal modifications that direct morphology changes
during diﬀerentiation.
Certainly in 2D culture, it seems that shear stress has
an overall net eﬀect of directing diﬀerentiation of MSCs,
preventing their proliferation and selecting cell subsets that
have osteogenic potential from those that do not. Subsequent
upregulation of osteogenic genes following MAP kinase-
dependent mechanotransduction then results in enhanced
calcified matrix production. However, tissue-engineering
approaches for bone regeneration require cell seeding onto
3D scaﬀolds, and so, it is necessary to take caution when
inferring observations from 2D fluid flow assays to scaﬀold-
based approaches.
4. Activation of Mechanotransduction
Pathways by Shear Stress
Integrin-mediated mechanotransduction is one of several
mechanotransduction pathways that are widely known to
promote osteogenic diﬀerentiation in response to mechan-
ical stimuli such as fluid flow shear stress. Diﬀerent ECM
molecules are capable of supporting osteogenic diﬀerentia-
tion of MSCs including type I collagen, fibronectin, laminin,
and vitronectin [55, 80, 81], and cells attach to these ECM
molecules via integrins. Fibronectin has the most potent
ability to promote osteogenic diﬀerentiation [55], likely due
to it is ability to activate α5β1 integrins, which are important
for the osteogenic process [82]. Osteogenic responses are
promoted not just by α5β1, but also via activation of
αvβ3 and possibly other β1-containing integrins [52, 55,
59]. These integrins mediate cellular attachment to several
diﬀerent matrix components including fibronectin, type I
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collagen, laminin, and vitronectin. However, the reason
that osteogenesis occurs most readily on fibronectin rather
than on type I collagen or laminin under fluid shear stress
[55] probably reflects the rapid and sustained activation
of α5β1 and αvβ3 receptors by fibronectin. Shear stress
upregulates α5β1 expression in MSCs used for production
of vascular grafts [83] and β1 subunit is itself upregulated
in osteoblasts by shear stress [50]. It is thought that this
is an important event for diﬀerentiation and ultimately
matrix mineralization not just in osteoblasts but also in
MSCs, where α5β1 activation by fibronectin is an important
regulator for osteogenic diﬀerentiation of MSCs both in 2D
and 3D culture [82]. Furthermore, fibronectin fragments
that specifically activated α5β1, rather than αvβ3, yielded
greater osteogenic responses [82].
Focal adhesions at sites of high integrin clustering and
activation mediate mechanotransduction pathways down-
stream of extracellular outside-in signals. FAK is a nonrecep-
tor tyrosine kinase that is essential for mechanotransduction
from the focal adhesion and if FAK signal transduction in
osteoblasts is blocked, osteogenesis mediated by fluid flow
shear stress is attenuated [84]. FAK is also essential for ECM-
directed osteogenic diﬀerentiation of MSCs [85], indicating
the general importance of mechanical activation of integrins
and FAK during osteogenic events.
Osteogenic diﬀerentiation and maturation in response to
mechanical stimulation by fluid shear stress is also dependent
on downstream activation of ERK1 and ERK2 proteins.
Several diﬀerent convergent signal transduction mechanisms
result in phosphorylation of ERK proteins upon mechanical
stimulation, and integrin signaling represents one such
mechanism. Shear stress-induced ERK activation can result
from upstream coupling of β1 integrin subunit with the
Shc adaptor protein [50, 55] and ERK phosphorylation
subsequently leads to transcriptional activation of osteogenic
genes including the potent osteogenic transcription factor
RUNX2 [81, 85].
A second key pathway that promotes ERK-mediated
osteogenic diﬀerentiation in response to fluid flow shear
stress is Ca2+ signaling [86]. Ca2+ signaling enhances pro-
liferation of MSCs in response to fluid flow [67], leading to
the activation of AP-1 transcription factors and consequently
expression of important osteogenic genes encoding type
I collagen, RUNX2 and osteocalcin [87–89], ultimately
promoting mineralized matrix formation [87]. Activation of
ERK downstream of Ca2+ signaling is mediated by calmodu-
lin-dependent protein kinase [87] and protein kinase C [89].
Nitric oxide is also produced in response to Ca2+-dependent
upregulation of nitric oxide synthase activity in MSCs [90].
Therefore, the reported increase in nitric oxide when cells
are exposed to shear stress [46] and during osteogenic diﬀer-
entiation [91] is likely a downstream event of cellular influx
of Ca2+. Nitric oxide itself can then participate in osteogenic
mechanotransduction by enhancing the phosphorylation of
ERK proteins [92].
The intracellular responses of MSCs to shear stress also
includes structural changes to the cytoskeleton [93, 94]
important for osteogenic diﬀerentiation to take place [95].
Recent studies indicate that Rho-mediated contraction of the
actin cytoskeleton seems to be critical for osteogenic diﬀer-
entiation of MSCs and further enhances RUNX2 expression
[96, 97]. Overexpression studies showed that RhoA signaling
via its eﬀector protein Rho-associated kinase (ROCKII) sig-
nificantly upregulated osteogenic diﬀerentiation in response
to oscillatory fluid flow whilst suppressing chondrogenic and
adipogenic induction [96]. However, in wild-type controls
oscillatory fluid flow was found to concurrently and indis-
criminately enhance expression of trilineage diﬀerentiation
markers Runx2, Sox9, and PPARγ, markers of osteogenic,
chondrogenic, and adipogenic diﬀerentiation, respectively
[96].
5. Bioreactors for Bone Tissue Engineering:
Impact of Shear Stress
Bone tissue engineering is an area of considerable interest,
as it would enable scalable production of autologous bone
material for regeneration within critical-sized skeletal defects
that do not regenerate well using current strategies such as
external fixing devices or implantable permanent materials
[98]. It would also eliminate the need to obtain sizeable
bone grafts from the patient, as MSCs isolated from the
bone marrow or even from more easily accessible sources of
multipotent cells such as adipose tissue could be expanded
to the required cell number and diﬀerentiated into appro-
priate osteoblast cells. Researchers in the field are already
capable of producing tissue-engineered bone in appropriate
clinical quantities [99, 100] and desired anatomical shape to
human bones [101]. One major challenge, however, is that
producing 3D tissues such as bone is not achievable using
conventional cell culture methods. This is because during
static culture of cell-seeded scaﬀolds, nutrient gradients
develop due to a lack of active nutrient transport to the
core of the tissue. Therefore, cells at the surface of the
scaﬀold receive adequate nutritional support, but this is at
the growing expense of cells located progressively closer the
center of the scaﬀold. Oxygen in the culture medium that
is delivered via passive diﬀusion can only support the 150–
200 μm thick outermost layer of cells in a scaﬀold [102, 103].
Consequently, when nutrient and oxygen levels decline below
a minimum threshold necessary for cell survival, the cells die
[32].
Development of bioreactors that facilitate even dis-
tribution of nutrients and oxygen to cells throughout a
3D scaﬀold using active transport methods have taken
considerable steps to addressing this fundamental challenge.
Several types of bioreactor have been extensively tested for
potential use in bone tissue engineering: spinner flasks,
rotating wall, and perfusion systems (for an excellent detailed
review, see [104]). These dynamic bioreactors, particularly
perfusion bioreactors, have successfully been used to enhance
cell-seeding eﬃciency and uniformity [36, 105–109] and
facilitate proliferation throughout the entire 3D structure
[34–36, 109–113]. Importantly, for bone tissue engineering
strategies, flow perfusion bioreactors have been successfully
demonstrated to promote osteogenic diﬀerentiation and
mineralization on scaﬀolds [38, 40, 109, 112–116] even in
the absence of dexamethasone [117]. Flow perfusion systems
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also seem to be superior to spinner flasks and rotating
wall bioreactors, as they result in more homogeneous
mineralized matrix formation throughout the scaﬀold when
compared to spinner flasks [106, 114] and spinner flasks
themselves induce greater osteogenic marker expression than
rotating wall bioreactors [111, 118]. These observations of
enhanced osteogenic responses in 3D perfusion bioreactors
are consistent when using stem cells derived from adipose
tissue [119] as well as bone marrow [120].
The responses of cells in 3D scaﬀolds to fluid flow shear
stress are dose-dependent [33, 38, 105, 112, 115, 121–123]
and it seems that a critical shear stress level exists, after
which point cell detachment and death occur [105, 122]. It
is particularly interesting to note that in two separate studies,
application of a low medium perfusion rate was stimulatory
to proliferation compared to higher perfusion rate, whereas
expression of osteogenic diﬀerentiationmarkers was elevated
at the higher perfusion rate relative to low perfusion [33,
123]. This indicates that a mechanical “switch” likely exists,
whereby mechanotransduction pathways due to mild fluid
flow shear stress promote proliferation and increasing levels
of stress beyond a given threshold promotes diﬀerentiation
at the expense of proliferation and self-renewal. This is an
important consideration, because ensuring that the appro-
priate cell number for functional bone formation is achieved
before initiating the program of osteogenic diﬀerentiation is
essential for creating the gold standard in tissue engineered
bone. According to studies by Zhao et al. [33] and Cartmell
et al. [123], maintaining shear stress at a magnitude that
is stimulatory to proliferation will achieve the required
cell number and subsequently raising shear stress above
the threshold that leads to diﬀerentiation will drive the
osteogenic response. With this in mind, an even greater
understanding of the biophysical environment in which
MSCs reside in vivo and the subsequent biophysical changes
that take place during the diﬀerent stages of bone healing
could provide useful indications of the change in mechanical
forces such as shear stress that required for enhanceing the
proliferation and subsequent diﬀerentiation and maturation
phases of osteoblast development.
A final important consideration for osteogenic induction
on 3D scaﬀolds in perfusion bioreactors is that mathematical
models of the eﬀects of shear stress on cell behavior
are mostly based on 2D culture conditions using cells in
monolayer, where the eﬀective parameters and outcomes can
be easily drawn. However, cells adhered to the surface of 3D
scaﬀolds are variable in their adhesion status (Figure 2(b)),
such as in the form of bridging (occupying a position in 3D
between several scaﬀold components) or flattened (firmly
adhered to a single section of scaﬀold in 2D) [124]. Under
flow perfusion culture these two diﬀerent cell arrangements
may diﬀerentially sense the fluid flow shear force. Cells bridg-
ing the scaﬀolds sense shear force with greater sensitivity
than those occupying a flattened 2D morphology as the flow
is more perpendicular to the cytoskeleton of the former cells
[125]. Therefore, the mechanical force generated on the cells
and the shear stress that is required for directing osteogenic
cellular processes is lower in the 3D cultured cells than in
2D culture. For example, studies focused on osteogenesis in
3D culture have employed fluid shear stress in the range of
0.01∼0.05 Pa [33, 94, 115, 126], which is far lower than the
stress ranges (0.1∼1 Pa) that are eﬀective for osteoinduction
in 2D culture [69, 96, 127]. It is also presumed that the
flattened subset of cells in 3D perfusion culture corresponds
to those under 2D laminar flow. As a result, during flow
perfusion culture, adhesion, proliferation and diﬀerentiation
of cells present in 3D scaﬀolds are considered to be more
variable and complicated than those in 2D culture under
laminar flow.
6. Conclusions
Regenerative medicine strategies for treatment of diﬃcult-
to-heal critical sized bone defects are a realistic goal and
tissue engineering approaches that incorporate regenerative
cell populations and appropriate biocompatible scaﬀold
materials are an exciting prospect for successful widespread
treatment of patients in the very near future. Bioreactors
that utilize perfusion culture systems are necessary to
overcome the limitations of standard cell-culture practice
by producing viable and structurally suitable tissues that
have uniform distribution of essential oxygen and nutrients
throughout the full depth of the tissue. Many studies have
shown that shear stresses inherent in perfusion culture are
extremely beneficial for enhancing osteogenic diﬀerentiation
and improving resulting matrix mineralization by activat-
ing appropriate mechanotransduction pathways that may
regulate osteogenesis in vivo. It is also evident that even
when adult multipotent cells in suspension are exposed to
fluid flow shear stresses similar to those that cells experience
during routine bioprocessing, osteogenic induction in those
cells is significantly enhanced. Therefore, shear stress can
be a powerful tool for enhancing cell diﬀerentiation that
will benefit many patients requiring cell therapy or tissue
engineering for bone regeneration.
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